Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Conversion from Peginesatide to Epoetin Alfa in Hemodialysis
NCT01737879Phase 4Terminated
- Sponsor
- Amgen
- Start
- Oct 2012
- Primary completion
- Mar 2013
- Modality
- Peptides, Polymer-based Nanoparticles
- Countries
- 1
01
Overview
A Phase 4 trial of peginesatide in anemia, sponsored by Amgen. Started Oct 2012; status: terminated.
02
Drugs
peginesatide
03
Conditions
anemia
Beyond the preview
Go deeper on NCT01737879.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01737879.